Geez rjs, keep your head up.
This must be old (like a
Geez rjs, keep your head up.
This must be old (like a month ago) since we know it was 33 samples (not about 30) and supposedly tested them already (not "plans to test the most promising peptide candidates in blood samples from recovered individuals). Stop posting old junk...lol.
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
BrainCo's Intelligent Prosthetic Bionic Hand Triumphs Recently, BrainCo's Intelligent Prosthetic Bionic Hand made headlines by securing a prestigious accolade at the CATON FAIR DESIGN AWARD. This event, held in Guangzhou, China, brought together numerous innovative products, but BrainCo's product stood out, earning the remarkable Best of the Best Award amidst tough...
Continue Reading
Morgan Stanley Embraces Bitcoin Investments Global investment bank Morgan Stanley has made a notable pivot in its investment strategy, showcasing a growing interest in stocks and investments related to Bitcoin this year. This shift comes despite the initial skepticism expressed by its executive chairman, James Gorman, regarding the cryptocurrency's viability as a core...
Continue Reading
POWERCHINA's Commitment to Sustainable Development Power Construction Corporation of China (POWERCHINA) is reinforcing its dedication to Environmental, Social, and Governance (ESG) principles through impactful sustainable infrastructure projects in Serbia. As the company continues to invest in this region, it has acknowledged the pressing need for efficient and...
Continue Reading
Transforming Lives: The Advancements in the Artificial Limbs Market The growth of the artificial limbs and joints market is propelled by cutting-edge technologies, increasing cases of limb loss, and a growing demand for customized prosthetics. Innovations such as bionic limbs, AI-integrated prosthetics, and state-of-the-art 3D-printed joints are significantly enhancing...
Continue Reading
Evergy's Upcoming Conference Call for Q3 2024 Results Evergy, Inc. (NASDAQ: EVRG) is set to release its earnings for the third quarter of 2024. This event is highly anticipated as the company aims to provide updates and insights regarding its performance. The conference call is scheduled for November 7, 2024, which will take place before the market opens. Details of the...
Continue Reading
